We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

E.U. Eyes Six-Month Marketing Exclusivity For Pediatric Testing

Law360 (September 29, 2004, 12:00 AM EDT) -- The European Commission has proposed legislation to encourage pharmaceutical companies to develop more pediatric drugs in return for extended patent rights.

Advanced by the European Union’s Consumer Affairs Commissioner Olli Rehn, the bill closely mirrors the six-month extension of exclusive marketing rights granted to U.S. pharmaceutical companies for pediatric research.

The proposal, put forth on Wednesday, will require new drugs to be tested specifically on children before they are cleared for pediatric use, and aims to stimulate new research into existing medicines.

Under the proposal, most...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.